Case Fatality Rate of COVID-19: Meta-Analysis Approach

Amir Almasi-Hashiani ¹ , Amin Doosti-Irani ² , Mohammad Ali Mansournia ³ *

Cited by CrossRef: 4

1- Mousavi-Hasanzadeh M, Sarmadian H, Safi F, Jamalian M, Almasi-Hashiani A. Epidemiological and Clinical Characteristics of Patients with COVID-19 in Arak, Iran. TOPHJ. 2020;13(1):712 [Crossref]

2- Hayashi K, Nishiura H. Time-dependent risk of COVID-19 death with overwhelmed health-care capacity in Japan, 2020–2022. BMC Infect Dis. 2022;22(1) [Crossref]

3- Hassani S, Sayyadi M, Almasi-Hashiani A. Plasma tissue factor pathway inhibitor levels in coronavirus disease 2019 patients: a systematic review and meta-analysis. 2024; [Crossref]

4- Noori M, Azizi S, Abbasi Varaki F, Nejadghaderi S, Bashash D. A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies. International Immunopharmacology. 2022;110:109046 [Crossref]

5- Ye Q, Zhang T, Lu D. Potential false‐positive reasons for SARS‐CoV‐2 antibody testing and its solution. Journal of Medical Virology. 2021;93(7):4242 [Crossref]

Submit Your Paper Notification Instructions for Authors Aims and Scope Editorial policies Editorial Board AIM old site Archive

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.